Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Improvised Nasal Naloxone Devices Might Deliver Insufficient Medication

By Will Boggs, MD (Reuters Health) | on April 11, 2019 | 0 Comment
Latest News
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

“INNDs may still have a place in overdose reversal, but their potential limitations must be considered,” he said. “These results showed a lower blood naloxone level after INND use, but the clinical significance of this difference is unknown.”

You Might Also Like
  • Naloxone Nasal Spray Approved by FDA for Opioid Overdose Treatment
  • Naloxone Distribution to Patients in Emergency Department Raises Controversy
  • Naloxone Distribution Strategies Needed in Emergency Departments

“It is worth adding that there are many unpredictable factors that can cause these antidotes to fail, and emergency services should also be contacted for a suspected overdose even if naloxone is successfully used,” Dr. Eggleston said.

Pages: 1 2 3 | Single Page

Topics: Drug AbuseDrug UseNaloxoneOpiod CrisisOpioids

Related

  • Prehospital Buprenorphine Is a Powerful Tool in the Opioid-Crisis Fight

    June 4, 2025 - 0 Comment
  • How to Manage Elderly Patient Pain without Opioids

    February 13, 2024 - 0 Comment
  • Managing Pain Relief in Palliative Care

    July 27, 2021 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

No Responses to “Improvised Nasal Naloxone Devices Might Deliver Insufficient Medication”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603